According to the UnivDatos Market Insights, growth in biopharmaceutical production, increased production of vaccines, global expansion of the biotech industry, technological advancements, and rising regulatory support drive the Bioprocess Bags market. As per their “Bioprocess Bags Market” report, the global market was valued at USD 3.85 Billion in 2023, growing at a CAGR of about 17.5% during the forecast period from 2024 - 2032 to reach USD Billion by 2032. With a constant focus on the improvement of manufacturing strategies, bioprocess bags are one of the distinctive must-have facilities for modern biopharmaceutical production for increasing effectiveness, scope, and productivity, as well as saving the environment. Since single-use technologies are now trending, the bioprocess bags market is speeding up as there are improvements in biologics manufacturing, personalized medicine, and vaccines. This paper reviews the current trends, new product developments, and issues in the bioprocess bags market.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=68909

The global biopharmaceutical market is segregating rapidly due to the growing incidences of chronic diseases, the shifting preference for biologic and biosimilar products, and the accentuated concentration on precision medicines. The following Bioprocess bags are particularly important in this growth, providing sterile, scalable, and cost-efficient flexible solutions for liquid handling, storage, and transport through upstream and downstream and final formulation steps. These are single-use items, which can help to minimize cleaning and sterilization requirements, the primary source of operational challenges in a sterilized environment.

Increasing Global Requirement of Bioprocess Bags

on March 28, 2022 — ILC Dover LP (“ILC Dover” or the “Company”), specializing in innovative single-use solutions for biotherapeutics and pharmaceutical processing, announced its launch of liquid single-use bioprocessing bags, representing the first of many new products for handling and supply of sterile liquids for the biotherapeutics market. This expansion is a continuation of ILC Dover’s solution set across the entire biotherapeutic and pharmaceutical manufacturing workflow, from powder containment and handling, through sterile liquid handling and pre-filled liquid and powder bags.

However, it is the COVID-19 pandemic that drew attention to such disposable products as bioprocess bags. It made them vital in vaccine production as they were able to scale production as soon as possible to meet the need to deliver billions of doses around the globe. Since governments and organizations are looking to the future and strengthening themselves for future pandemics, the need for bioprocess bags will continue.

Technological Adoptions and Discoveries

Biopharmaceutical manufacturers are producing polymeric films of high strength, durability, and chemical resistance to achieve the demanding biopharmaceutical manufacturing standards. These developments also guarantee that bioprocess bags are capable of withstanding various production challenges while still providing sterility and dependable quality.

Another major field of development is automation compatibility. Manufacturers of biopharmaceutical products, which have adopted the use of automated systems primarily in order to improve productivity, potentially do so with an appreciation of the role of bioprocess bags with regard to compatibility with these systems. This trend is especially apparent in downstream processing, for example, chromatography and filtration where automation is a strong aspect.

Another factor being adopted socially by bioprocess bag manufacturers is sustainability. Realizing more about environmental issues, producers are looking for environmentally friendly materials and recycling to reduce the scale of the environmental effects of disposable technologies. For example, several manufacturers are working in recyclable bioprocess bags and have been partnering with some recycling firms to ensure efficient waste disposal systems.

On April 24, 2023 – Merck, a leading science and technology company, announced the launch of its Ultimus® Single-Use Process Container Film, designed to provide extreme durability and leak resistance for single-use assemblies used for bioprocessing liquid applications.

On August 17, 2023, Sartorius and Repligen Corporation announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ATF upstream intensification technology into Sartorius’ Biostat STR® bioreactor, simplifying intensified seed train and N perfusion implementation for biopharmaceutical manufacturers.

Key Drivers and Opportunities

The bioprocess bags market is driven by the following factors; this is because of the usage of single-use systems the production rate of Biologics and vaccines in the market, innovative development of cell & gene therapy. Single-use technologies have several benefits compared to the conventional steel system including; lower contamination levels, faster setup time, and versatility in scaling up production.

The Asia-Pacific and Latin American markets have the potential to offer considerable growth opportunities for bioprocess bag makers. Governments of such regions are increasingly participating in the development of biopharmaceutical capability for domestic production and to cut import dependency. This expansion is likely to create a need for bioprocess bags since organizations are likely to set up new production units to meet both local and international needs.

On June 1, 2021, Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, announced that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Industry players are another factor that contributes to market growth, such as contract manufacturing organizations (CMOs) and contract research organizations (CROs). Such organizations have come to depend on bioprocess bags for affordable, spacious, and versatile production services for customers. As the industry undergoes outsourcing of production and research activities, the market for bioprocess bags will continue to expand.

Future Outlook

The market for bioprocess bags has promising scope for future growth and is expected to grow rapidly in the next few years. By market estimates, the industry is expected to achieve a CAGR above 10% by 2030 mainly due to rising interest in biologics, biosimilar, and cell and gene therapies.

This indicates that as advancement is set to continue defining the industry, bioprocess bags will feature further in biopharmaceutical production. Promises of advanced automation, online diagnostics and monitoring, and greener, lighter, and better-performing materials indicate longer-term growth prospects for the bioprocess bag application.

Click here to view the Report Description & TOC https://univdatos.com/report/bioprocess-bags-market/

Conclusion

Bioprocess bags are now becoming popular in biopharmaceutical production in that they have unique advantages in that it is efficient, scalable, and inexpensive. These single-use technologies will continue to be more and more applicable to the process needs of the new challenges of the modern biomanufacturing industry. The bioprocess bags market is changing dynamically because of new developments, mergers, and acquisitions, and increasing orientation towards sustainability in the production process in the coming years.

Related Healthcare Market Research Report

Colorectal Cancer Market: Current Analysis and Forecast (2024-2032)

Polymer-Based Prefilled Syringe Market: Current Analysis and Forecast (2024-2032)

Pipette Tips Market: Current Analysis and Forecast (2024-2032)

Dental Connected Technology Solutions Market: Current Analysis and Forecast (2024-2032)

Contact Us:

UnivDatos Market Insights

Email - [email protected]

Contact Number - +1 9782263411

Website - https://univdatos.com/

Linkedin- https://www.linkedin.com/company/univ-datos-market-insight/mycompany/